ATLASMiNK Therapeutics (INKT) earnings date: Nov 13, 2026
MiNK Therapeutics (INKT) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.50.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on INKT
| Last price | $10.97 (+4.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.8% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the MiNK Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
MiNK Therapeutics reports on Nov 13, 2026. One email the day before, with ATLAS’s read on MiNK Therapeutics. You can switch it off at any time.
Alert me before INKT reportsFree to start. Creating an account takes under a minute.
Notify me when MiNK Therapeutics reports
Track INKT free Add MiNK Therapeutics to a free ATLAS watchlist and see its next report date in one place.
INKT earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.50 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +12.0% |
| Average move around a report | ±1.8% (last 4) |
| Sector | Healthcare · Biotechnology |
MiNK Therapeutics earnings history: last 4 reports
MiNK Therapeutics last reported on Aug 13, 2026: EPS of -$0.62 against an estimate of -$0.60 (-3.3% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.60 | -$0.62 | -3.3% | Miss | -0.8% |
| May 15, 2026 | -$0.77 | -$0.57 | +26.0% | Beat | -4.5% |
| Mar 31, 2026 | $0.59 | $0.66 | +11.9% | Beat | +0.5% |
| Feb 13, 2026 | $0.44 | $0.50 | +13.6% | Beat | +1.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for INKT
See the fair value, the probability range and the earnings history of MiNK Therapeutics on its ATLAS page.
MiNK Therapeutics (INKT) stock analysisPlans from €3.99 a month.
MiNK Therapeutics earnings: frequently asked questions
When does MiNK Therapeutics (INKT) report earnings?
MiNK Therapeutics is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for INKT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.50 per share (USD). Estimates can change before the report.
How often does INKT beat earnings estimates?
Of its last 4 reports with a recorded result, MiNK Therapeutics beat the EPS estimate 3 times; the average surprise was +12.0%. Past results do not predict the next one.
How much does INKT move around earnings?
Over its last 4 reports the stock moved an average of 1.8% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
Did MiNK Therapeutics beat earnings estimates last quarter?
MiNK Therapeutics last reported on Aug 13, 2026: EPS of -$0.62 against an estimate of -$0.60 (-3.3% surprise), a miss.
How much does INKT usually move in a day?
On a normal trading day the ATLAS model puts INKT’s one-day range at about ±3.8%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer